Toward the Discovery of Novel Anti‐HIV Drugs. Second‐Generation Inhibitors of the Cellular ATPase DDX3 with Improved Anti‐HIV Activity: Synthesis, Structure–Activity Relationship Analysis, Cytotoxicity Studies, and Target Validation
Giovanni Maga(National Research Council), Maurizio Botta(University of Siena), Samantha Zanoli(Istituto di Genetica Molecolare), Alberta Samuele(Istituto di Genetica Molecolare), Marco Radi(University of Siena), Stefania Paolucci(Policlinico San Matteo Fondazione), Fabrizio Manetti(University of Siena), Fausto Baldanti(University of Pavia), Federico Falchi(University of Siena), Zeger Debyser(Gene Therapy Laboratory), José A. Esté(Universitat Autònoma de Barcelona), Elisa Zucca(Istituto di Genetica Molecolare), Lorenzo Botta(University of Siena), Martina Bernardini(University of Siena), Anna Garbelli(Istituto di Genetica Molecolare), Gianni Casaluce(University of Siena), Hamid Irannejad(Mazandaran University of Medical Sciences), Emmanuel González(Inserm), Jan De Rijck(KU Leuven)
Cited by 105
Related Papers
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
|Journal of Cell Science|2003|1.1k
Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients
|Journal of Medical Virology|2006|176
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|132